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ABSTRACT 
Metabolic profile and post-operative outcomes in contemporary patients with peripheral arterial 
disease and critical limb ischaemia- an observational prospective cohort study 
Authors: Lily Wu, MBChB (GH), FWACS (GH), Cert Vascular Surgery (SA), Nadraj G. Naidoo, 
MBChB, FCS (SA), Department of Vascular and Endovascular Surgery, Groote Schuur Hospital, 
University of Cape Town, Cape Town, Republic of South Africa. 
Background: Peripheral arterial disease (PAD) is an established occlusive disease of the peripheral 
arteries and is not uncommon in the elderly. Atherosclerosis accounts for 90% of the pathology. Only 
15% of affected individuals become symptomatic. Most symptomatic individuals present with 
intermittent claudication (IC). Only a small proportion (1%) of affected individuals present with 
critical limb ischaemia (CLI). Revascularization aimed at limb salvage, and recovery of ambulation 
and independent living is the ultimate therapeutic option for the advanced form of PAD (CLI). 
Traditionally, the success of revascularization for CLI has been defined by graft patency rates and 
limb salvage rates. Functional outcomes such as ischaemic wound healing and recovery of ambulatory 
function for independent living have been the focus in more recent publications. However, these 
assessments do not consider the patients’ pre-operative metabolic profile as a predictor of post-
operative outcomes. 
Purpose: The purpose of this study was to determine, in a prospective manner, the influence of pre-
operative metabolic profile on post-operative outcomes in contemporary patients with peripheral 
arterial disease presenting with critical limb ischaemia at a tertiary hospital in South Africa.  
Methods: All consecutive patients, ³18 years with CLI admitted to the vascular unit at Groote Schuur 
Hospital over a two-year period (1st January, 2015 to 31st December, 2016) with reconstructable 
disease were recruited for the study. Written informed consent was obtained from all participants. 
Revascularization entailed either open surgical revascularization, endovascular interventions or both 
(hybrid procedures). Data was analyzed according to the clinical level of disease and the type of surgical 
intervention. Post-operative outcome measures were determined.  
Primary endpoints (functional and technical outcomes) 
• Ambulatory recovery at six months and one year
• Complete ischaemic wound healing at six months and one year
• Limb salvage rate at six months and one year
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•   Primary graft patency rate at six months and one year 
 
Secondary endpoint  
•   The influence of pre-operative metabolic profile on the post-operative outcomes  
The association between pre-operative metabolic profile and post-operative outcomes was determined 
by Pearson Chi-square statistical test and logistic regression model. 
 
Results: A total of 73 consecutive patients were recruited for this study with a mean age of 58 ± 9 years 
(Range: 30 - 75 years). Seventeen patients (23.3%) had rest pain and 56 (76.7%) had tissue loss. Current 
smokers and previous smokers constituted 86% of the sample population with a male to female ratio of 
approximately 1:1. Our study population was generally overweight based on the BMI. There was high 
prevalence of abdominal obesity and high body fat for both males and females.  
Recovery of ambulatory status was 69% and 67% at six months and one year follow-up respectively. 
The rate of ischaemic wound healing at six months and one year was 48.2% and 75.0% respectively. 
Surgical site sepsis was the most common local wound complication. Limb salvage rate was 78% and 
79% at six months and one year respectively. Overall primary graft patency at six months was 69.0% 
but reduced to 60.0% at one year. Major amputation rate at one year was 21%. Most of the post-
operative wound-related complications occurred among patients with diabetes. More diabetic patients 
had major amputations compared to non-diabetic patients (57.9% vs 42.1%). One year amputation-free 
survival (AFS) was 69.9%. There were no statistically significant associations between metabolic 
profile of patients and post-operative clinical outcomes.  
 
Conclusion: Demographics, co-morbidities, and procedural details of our study population, reflected a 
relatively younger population with CLI. The profile of this contemporary vascular surgery patients is 
that of overweight, high abdominal obesity, and high prevalence of smoking among both gender. The 
technical and functional outcomes observed in this study are consistent with available western literature. 
Diabetes was associated with prolonged ischaemic wound healing, higher risk of major amputation and 
local wound complications. A statistically significant association was not found between patients’ 
metabolic profile and post-operative outcome but this could be due to the small sample size and short 
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BACKGROUND 
Peripheral arterial disease is defined, anatomico-pathologically, as established chronic occlusive disease 
of the peripheral arteries with specific reference to the lower limbs. Peripheral arterial disease (PAD), 
from a community screening perspective, is defined as an ankle-brachial pressure index (ABI) of less 
than 0.9 (1), (2), (3). 
 
Diagnosing PAD using ABI Clinical significance 






Atherosclerosis forms the pathological basis for approximately 90% of PAD. In the western literature, 
PAD is generally synonymous with atherosclerotic PAD. Peripheral arterial disease usually co-exists 
with atherosclerosis in other vascular beds.  Consequently patients with PAD  are at an  increased risk 
of stroke, myocardial infarction and cardiovascular death (4). A low ABI is a potent surrogate marker 
for future cerebrovascular and cardiovascular events (5), (6), (7). 
The prevalence of PAD varies widely and increases dramatically with increasing age (1), (2), (3). It 
ranges from 3% to10% generally, but increases to 20% in persons over 70 years (8). There are also 
some racial differences in the prevalence of PAD. It disproportionately affects blacks (3). Age-adjusted 
estimates showed that non-Hispanic blacks and Mexican-Americans had a higher prevalence of PAD 
than non-Hispanic Whites (19.2%, and 15.6% respectively) (3). Dominant risk factors for PAD include 
advancing age, smoking, diabetes mellitus, hypertension and hyperlipidaemia (1), (2), (3), (4).  
The vast majority of affected individuals with established PAD are asymptomatic. It is estimated that 
for every symptomatic individual with PAD, 3-4 individuals with PAD are asymptomatic. Being 
asymptomatic does not protect individuals with PAD against cardiovascular and cerebrovascular 
events, and vascular death. These patients have a reduced life expectancy compared to individuals 
without PAD. It has been shown that effective risk factor control is associated with a reduction in 
cardiovascular events and mortality in individuals with peripheral arterial disease (6), (9). The 
principal complimentary aims in the treatment of PAD is to reduce the risk of cardiovascular events 
such as myocardial infarction and stroke as well as to provide symptomatic relief.  Comprehensive 
management of PAD emphasizes optimum medical treatment (OMT) in all patients with PAD.  
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Lifestyle modification includes weight loss in overweight individuals, exercise therapy (preferably 
supervised exercise programmes) and smoking cessation strategies (4), (10), (11). Smoking cessation 
lowers the risk of PAD but not to the same degree as lifetime non-smokers (12), (10), (13). Optimum 
medical treatment is informed currently by evidence-based pharmacotherapy. Currently antiplatelet 
therapy and lipid-lowering strategies emphasizing statins constitute the medical standard of care in 
patients with established PAD. Antiplatelet therapy has been proven to be effective in secondary 
prevention of cardiovascular events (14). Target blood pressure control to <140/90 mmHg in patients 
with documented PAD, and <130/80 mmHg in patients with other atherosclerotic risk factors like 
diabetes or renal insufficiency is recommended. Good plasma glucose control (HbA1c <7%, current 
American Diabetes Association guidelines on treatment goal for all patients with DM) in individuals 
with diabetes is also desirable (4), (15), (16), (17). Adherence to these guidelines leads to  a 
significant reduction in major adverse cardiovascular events as well as fewer major adverse limb 
events (18).   
Revascularization strategies are generally reserved for the treatment of the advanced form of PAD, viz, 
severe life-style limiting, medically refractory claudication, and critical limb ischaemia (CLI). 
Revascularization strategies include endovascular interventions, open surgical vascular procedures or 
both (hybrid procedures). Generally open vascular surgical intervention for PAD is associated with not 
insignificant post-operative morbidity and mortality. Specific early post-operative complications 
include local wound complications (haemorrhage, hematoma, wound sepsis, etc.) early graft infection 
and early graft thrombosis. Late complications include late graft occlusion, late graft sepsis, anastomotic 
aneurysms, etc. Wound-related complications may necessitate re-admission and further surgical 
procedures. Thus, patients with CLI sometimes experience protracted post-operative recovery 
accompanied by multiple re-operations and hospital admissions. In some cases, the post-operative 
wound complications result in major amputations which impacts negatively on quality of life (social 
isolation and depression) (4). Productivity in terms of work and income is also adversely affected. 
Caring for such physically disabled individuals by family and caregivers is also a challenge. Many of 
the individuals who ultimately undergo major amputations are in some cases financially supported by 
Social Welfare through monthly stipends. This adds further burden on the already limited economic 
resources available in developing countries. The traditional measures that have historically been used 
to determine the success of operative interventions are limb salvage and graft patency. Functional 
outcomes such as ambulatory recovery and  ischaemic wound healing however have been shown in 
recent reports to be better outcome measures to assess clinical success of operative interventions for 
CLI, (19), (20), (21), (22), (23).  
Factors that may influence post-operative outcomes may include pre-operative metabolic profile, risk 
factors for atherosclerosis, clinical level of disease, concurrent co-morbidities, the type of 
revascularization procedure, surgical expertise and duration of surgery. In patients with CLI and tissue 
loss, ischaemic wound healing is confounded by the extent of revascularization, the presence of diabetes 
Page	   16	  
mellitus, sepsis and metabolic profile. Optimal metabolic support is required for adequate recovery of 
patients following any surgical operation including vascular interventions. Such optimal metabolic 
support limits catabolism, promotes wound healing, and mobilizes appropriate defense mechanisms 
against infection (24). The metabolic profile refers to an individual’s physical/physiological wellbeing 
assessed by anthropometric measurements and haematological/biochemical evaluation. It is a measure 
of one’s immune competence to withstand adverse events like trauma, major surgery and infections. It 
is also a measure of the body’s wound healing capacity. Patients with metabolic syndrome are known 
to have increased insulin resistance and to be at increased risk for adverse cardiovascular events (25). 
Nutritional status of patients has been proven to influence surgical outcome in terms of post-operative 
complications (26). Anthropometric measurements, haematological and biochemical tests are proven 
methods of evaluation of the metabolic profile (27), (28). Anthropometric measurements such as mid-
upper arm circumference (MUAC) provides a measure of muscle mass while triceps skin fold thickness 
(TSFT) provides an excellent index of body fat. These methods are more accurate in their assessment 
of protein-based nutritional status (24). Serum transport proteins (i.e. albumin, pre-albumin, and 
transferrin) are good indicators of visceral protein mass. Pre-albumin and transferrin levels are highly 
sensitive indicators of nutritional status. However, their levels change erratically during stress and 
illness. In addition to this limitation, the cost of determination of pre-albumin and transferrin levels are 
very high making them universally unacceptable tools for  routine clinical use (24). Albumin is 
synthesized in the liver and has a half-life of 18 to 21 days. Total albumin varies from 3 to 4g/kg in 
women and 4 to 5g/kg in men. Of these three blood tests, serum albumin is the most useful measure of 
nutritional status (29), (30). Albumin level of < 3.5 g/dl is associated with increased morbidity in 
intensive care unit and other hospitalized patients (31). Malnutrition has been linked to increased length 
of hospital stay, increased costs of treatment, and higher rates of complications (32). In surgical patients, 
poor pre-operative nutritional status has been associated with high post-operative morbidity and 
mortality (33). Post-operative complications and deaths were found to be more likely if patients were 
malnourished (34). Malnourished adult patients are usually underweight with a body mass index (BMI) 
≤18.5. A low BMI < 15 is associated with significant increase in post-operative morbidity (35), (36). 
BMI <18.5 is associated with a longer stay in intensive care unit, increased risk of post-operative 
complications and higher re-admission rates (36).  
Conversely, being overweight (25 <BMI≤29.9) or obese (BMI ≥ 30) also influence surgical outcome 
with respect to morbidity (wound-related complications, length of hospital stay, deep vein thrombosis, 
etc.) and mortality (34), (37). In a study by Lemaignen et al. to evaluate the risk factors for surgical site 
infection after cardiac surgery, advancing age, obesity and diabetes mellitus were among the risk factors 
identified (38). In another study on the effect of BMI on the 30-day morbidity and mortality involving 
vascular surgery patients, obesity was associated with the highest morbidity (34). Nam et al. also 
reported a higher risk of wound complications with infra-inguinal vein bypass graft in obese patients 
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(39). In patients with thigh arterio-venous shunts, obesity was associated with increased access failure 
and significant re-intervention rate(40).  
However, Nicholson et al., reported that obesity was not a risk factor for complications  following 
vascular reconstructive surgery (37). Gurm et al, similarly, found no association between BMI and early 
outcomes following carotid angioplasty and stenting (CAS) (41). Chang et al., also did not observe any 
significant association between obesity and wound infection rates after lower extremity 
revascularizations (42). Thus, the data available currently is contradictory with respect to the effect of 
patients’ metabolic profile on post-operative outcomes. The paucity of literature locally regarding this 
subject necessitates a study to interrogate the issue. Besides, the conflicting report as shown above 




















Page	   18	  
ABSTRACT 
Background: Peripheral arterial disease (PAD) is an established occlusive disease of peripheral 
arteries; particularly the lower limbs and is not uncommon in the elderly (1). Only a small proportion 
of individuals with PAD (15%) are symptomatic. An even smaller proportion (1%) present with CLI 
(43). The major risk factors for atherosclerotic PAD  include advancing age > 55 years, smoking, 
diabetes mellitus, hypertension and hypercholesterolemia. PAD is an independent risk factor for cardiac 
events (44). Hence individuals with PAD generally have shorter lifespan relative to an age matched 
cohort without PAD. The present review evaluated the current literature on surgical outcomes of 
patients with CLI, and assessed any associated pre-operative predictors of post-operative outcomes.  
Methods: PubMed/Medline, Google scholar and Cochrane databases were systematically searched 
for relevant English-language articles published between January 2007 and December 2016 (10 years 
period) using the terms “peripheral arterial disease AND critical limb ischaemia,” “peripheral arterial 
disease AND post-operative outcome,” etc. Selected articles were screened first by title and abstract. 
Full-text articles were subsequently screened using our inclusion and exclusion criteria and quality 
ratings were performed with the MINORS score. The primary endpoint was a composite of post-
operative technical and functional outcome measures.  The secondary endpoint was identification of 
predictors of post-operative outcomes. 
Results: A total of 2,114 articles were identified. Only six articles met our eligibility criteria and were 
deemed suitable for analysis. Ambulatory recovery was >70% at six months, and 86.7%, 73.0%  and 
70.6% at one year, three years and five years respectively. Local wound complications recorded were 
between 12% and 24%. In some studies >50% of the ischaemic wounds took more than three months 
to heal. In one study the wound healing rate at six months and one year was 42% and 75% respectively. 
Reported limb salvage rates were >90% at six months, >70% at one year and 70.0-90.0% at five years. 
Primary graft patency rate at one year ranged from 63% and 76.6%. Gangrene, diabetes and impaired 
pre-operative ambulatory function are associated with more wound complications, low limb salvage, 
reduced graft patency and poor functional outcome (19,  (21), (45), (46), (47). 
Conclusion: Multiple factors predicted post-operative outcomes, but none of the studies considered 
patients’ pre-operative metabolic profile. Pre-operative ambulatory status was the most important 
predictor of post-operative ambulatory recovery. Diabetes mellitus was an important risk factor for 
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Keywords:  
Peripheral arterial disease, critical limb ischaemia, post-operative outcomes 
 
INTRODUCTION 
The prevalence of peripheral arterial disease varies widely and increases with increasing age (1), (3). In 
the National health and nutrition examination survey (NHANES), the overall prevalence was reported 
as 4.3%. For people between 40 and 50 years, the prevalence was only 0.9% but for those older than 70 
years, the prevalence was 14.5% (1). Only a small proportion of individuals with PAD (about 15%) are 
symptomatic. An even smaller proportion (1%) present with CLI (43). The Reduction in 
Atherothrombosis for Continued Health Registry (REACH) study reported that asymptomatic 
individuals with PAD have a prognosis almost as poor as those with symptomatic disease (48). 
Peripheral arterial disease is an independent risk factor for cardiac events (44). Hence individuals with 
PAD generally have shorter life expectancy relative to an age matched cohort without PAD. The  
cardiovascular event rate  in individuals with PAD is considerably higher compared  to patients with 
cerebrovascular disease or even coronary artery disease (6). The risk of PAD among current smokers is 
4 times higher than non-smokers with a dose-related association clearly established. Diabetes mellitus 
is rapidly emerging as potent risk factor for atherosclerotic PAD. For every 1% drop in HbA1c, there 
is a corresponding 28% reduction in risk of PAD. In hypertensive patients, for every 10 mmHg drop in 
systolic blood pressure there is an associated 10% risk reduction in cardiovascular mortality (8).  




Literature search: PubMed/Medline, Google scholar and Cochrane databases were systematically 
searched for relevant English-language articles published between January 2007 and December 2016 
(10-year period) using the terms “peripheral arterial disease” AND “critical limb ischaemia,” 
“peripheral arterial disease” AND “post-operative outcome,” and “critical limb ischaemia” AND “post-
operative outcomes or complications”. Selected articles were screened first by title and abstract, and 
selection was based on relevance. Full-text articles were subsequently screened using our inclusion and 
exclusion criteria and quality ratings performed with the MINORS score (49).  
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Fig 1: MINORS Score(49) 
 
Inclusion criteria: All published articles involving patients’ metabolic and or risk factor profile and at 
least three post-operative outcome measures (technical, functional or both) 
 
Exclusion criteria: Reviews, case reports, abstracts only, meta-analysis, articles that require payment 
to access, non-English articles and duplicate articles. 
 
Primary endpoint:  
•   Technical and/or functional post-operative outcomes 
Secondary endpoint:  
•   Predictors of post-operative outcomes 
Validity assessment: Article screening, selection and data extraction were done by two reviewers 
independently to minimise bias. Identified relevant titles were selected as an initial step. All abstracts 
were read, and articles with clearly stated objectives of evaluation of predictors of post-operative 
outcomes or complications of surgical treatment of CLI were chosen. Using our eligible criteria, 
selected full articles were read, and selection made based on the presence of at least three of the outcome 
measures as defined in the reporting standards of revascularization for CLI (technical outcome 
measures) and/or functional outcomes or both. All related publications/electronic links of the selected 
articles were downloaded and the references perused to generate any further relevant publications. The 
quality of the selected articles was assessed using the Methodological Index for Non-Randomized 
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Studies (MINORS) quality score, with a maximum score of 16 for non-comparative studies and 24 for 
comparative studies (49).  
 
Table 1: MINORS Score (6 Best performing Studies) 
MINORS Score Study Number (see KEY) 
1 2 3 4 5 6 
A clearly stated aim 2 2 2 2 2 2 
Inclusion of consecutive patients 2 2 2 2 2 2 
Prospective collection of data 0 0 2 0 0 0 
Endpoints appropriate to the aim of the study 2 2 2 2 2 2 
Unbiased assessment of the study endpoints 2 2 2 2 2 2 
Follow-up period appropriate to the aim of the study 1 2 2 0 2 2 
Loss to follow up less than 5% 2 0 2 0 0 0 
Prospective calculation of the study size 0 0 0 0 0 0 
Total 11 10 14 8 10 10 
 
KEY: 1. Goshima et al, 2. Taylor et al, 3. Taylor et al 4. Abou-Zamzam et al,  
           5. Nicoloff et al, 6. Chung et al. 
 
RESULTS 
Description of studies 
The literature search yielded 2,114 publications. A total of 1,147articles were selected after excluding 
irrelevant articles based on the titles and abstracts. With the application of our inclusion and exclusion 
criteria, 821 articles were selected over a 10-year period ending December, 2016. Based on human 
subjects above the age of 19 years, 590 articles were  identified. Only six publications were identified 
as suitable for our study with three or more post-operative outcome measures (Fig 2). All six articles 
investigated three or more post-operative outcome measures (technical and/or functional). Technical 
outcome measures were based on the standards for reporting by the Society for Vascular 
Surgery/International Society for Cardiovascular Surgery (50), (51). The selected studies were of 
moderate quality using the MINORS scoring scale (Table 1). Five of them were retrospective studies 
and one was a prospective study (49). The six studies included a total of 2,446 patients (Table 2). The 
study population was grouped based on the investigated outcome measures and timelines at which the 
outcomes were assessed. 
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Total	  records	  identified	  through	  
database	  search	  	  	  n	  =	  2114 
PubMed/MEDLINE	  n	  =	  1311 
Cochrane	  	  	  	  	  	  	  	  	  	  	  	  n	  =	  22 
Google	  Scholar	  n=	  781 
Records	  excluded	  due	  
to	  irrelevance 
n	  =	  967 
Articles	  excluded	   
n	  =	  326 
Full	  text	  articles	  involving	  human	  
subjects 
n	  =	  1147	   
Articles	  excluded 
n	  =	  231 
Articles	  from	  January	  2007	  to	  
December	  2016	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
n	  =	  821 
Journal	  only	  (involving	  adults	  
19yrs+) 
n	  =	  590 




n	  =	  576 
Journals	  excluded 
n	  =	  8 
Journals	  with	  at	  least	  3	  post-­‐	  operative	  Outcomes	  
(technical	  and/or	  functional	  outcomes) 
6 
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Table 2a: Included Studies 
Study 𝑛  Type of Study Follow up 
(months) 
Type of operation 
Goshima et al 
2004 
315 Retrospective Not reported IBS 
Taylor et al 2007 331 Retrospective 72 IBS 
SIB 







513 Retrospective Not reported IBS 
Nicoloff et al 1998 112 Retrospective 36 IBS 
Chung et al 2006 334 Retrospective 30 IBS 
Total 2,446    
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Table 2b: Included Studies 
Study Goshima 















6 months    94.2 94.9 85 
1 year  80.6 76.5    
3 years     93.5 79.0 





6 months    92.0 93.1  
1 year   76.6   63.0 
3 years     87.6 50.0 





6 months    80.0 92.0 72.0 
1 year  86.7     
3 years     73.0  




6 months 54.0   12.0  42.0 
1 year      75.0 
 
Outcome measures and predictive factors 
Ambulatory recovery varied significantly, averaging 72% to 92% at six months; 86.7% at one year; 
73% at three years and 70.6% at five years. Rates of local wound complications  reported  were between 
12% and 24%. In some studies more than 50% of the ischaemic wounds took  longer than three to four 
months to heal. In one study the wound healing rate at six months and one year was 42% and 75% 
respectively. Reported limb salvage rates were from 94.2% at six months to 76.5-85.0% at one year. 
The five years’ limb salvage rates were 72.1-91%. Primary graft patency rate at one year was between 
63% and 76.6%. On the whole 30-day mortality was <1% in most reports but one study reported 6.3%. 
Re-operation rates varied from 48.9% at three months to 50.5% at three years. Major amputation rates 
varied widely from 3.5% at three months to 23.2% at three years. Survival at six months, one year and 
five years were >80%, 89% and 48% respectively. 
Multiple factors influence post-operative outcome. Tissue loss, high serum creatinine and diabetes 
(raised fasting plasma glucose) are associated with multiple re-operations and prolong wound healing 
(19), (45). Gangrene, diabetes, ESRD and impaired pre-operative ambulatory function predict low limb 
salvage, reduced graft patency and functional outcome (21), (46). Pre-operative impaired ambulatory 
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function  was reported in most of the studies to be the most important predictor of sub-optimal post-
operative functional outcome (21), (46), (47). A composite endpoint of limb salvage and ambulation at 
one year, survival at six months and graft patency up to the point of healing was achieved in only 44% 
of patients (20).  
Some studies also investigated predictors of post-operative outcome but the spectrum of outcome 
measures assessed were fewer than the minimum of 3 selected for our study and therefore were excluded 
(52), (22). Other studies which investigated only one type of surgical intervention like PTA were 
excluded and studies with sample population of patients who had re-intervention for failed previous 
vascular interventions were also excluded (Table 3) (53), (54).  
A total of six eligible studies reported seven outcomes of interest, however only five studies were used 
in conducting the meta-analysis. The study that was excluded from meta-analysis did not report the 
outcomes at the time lines of interest (see Table 2) (40-43, 68). Four studies were retrospective and one 
was prospective. Table 2 summarizes the included studies showing the number of patients, types of 
study, follow up, type of operation and outcomes. A total of 2,446 patients were included in this review.  
 
Table 3: Excluded Studies 
Study  Type of study n Reason for exclusion Conclusion  
Kudo et al Retrospective  192 
Different objective 
(procedure volume over 
different time-period and 
outcomes) 
open revascularization for the 
treatment of CLI have been 




Vinit et al  331 Review 
Patients with CLI should be 
offered revascularization  
if the procedure can be 
tolerated and the patient is 
ambulatory and living 
independently preoperatively. 
Amputation should be 
considered if the above criteria 
is not met.  
Goodney et al Retrospective 2,031 
<3 post-operative 
outcome. Examined risk 
factors that predict 
amputation or graft 
Risk factors can predict the 
risk of amputation and graft 
occlusion post-
revascularization for CLI 
Page	   26	  
occlusion within the first 
year following lower 
extremity bypass. 
Simons et al Retrospective 513 
Less than 3 post-
operative outcome 
measures investigated 
(assessed predictors of 
clinical failure defined as 
amputation and 
worsening ischaemia at 1 
year) 
10% of patients with patent 
grafts at 1year still could not 
attain clinical success. One of 
the predictors of failure to 
attain clinical success was 
ESRD. 
Rutherford et al   Review  
The initial published standards 
for reporting post-operative 
outcome for CLI requires 
periodic revision 
Gibbons et al Retrospective 318 Qualitative study 
Baseline health status is a 
predictor of post-operative 
functional recovery and well-
being. 
 Kudo et al  Retrospective 111 
Evaluated post-operative 
outcome (effectiveness) 
of only percutaneous 
transluminal angioplasty 
(PTA) 
PTA is feasible, safe and 
effective for the treatment of 
CLI 
Ambler et al Retrospective 90 Evaluated only 1 
outcome measure, 
ambulation 
Poor pre-operative ambulation 
predict poor post-operative 
ambulation and long LOS 
Total   3,586   
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Figure 3a: Forest plot of meta-analysis of the proportion estimates for post-operative outcome: 




 Limb salvage  
All 6 studies reported on limb salvage but at different time lines and follow up periods. At five years 
follow up, only three studies reported limb salvage outcome with Goshima et al reporting the highest 
percentage of 90.9% (40). The calculated pooled effect proportion using random-effects model among 
the three studies was 83.2%; (95% CI 71.0 to 92.6; n = 1672), with statistically significant heterogeneity 
(Cochran's Q test = Q = 69.4 on 2 degree of freedom, P <.0001, I2 = 97%). Considerable heterogeneity 
existed between the three studies (Figure 3a). 
Meta-­analysis
0.6 0.7 0.8 0.9 1.0
Proportion
Goshima  et  al  2004
Taylor  et  al  2007






95% CI Weight (%) Test for heterogeneity 
Random Q 69.3607 
Goshima et al 2004 318 90.881 87.166 to 
93.807 
32.82 DF 2 




P < 0.0001 
Abou-Zamzam et al 
1997 








1672 83.229 70.999 to 
92.617 
100.00 95% CI for 
I2 
94.24 to 98.56 
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Figure 3b: Forest plot of meta-analysis of the proportion estimates for post-operative outcome: 











Nicoloff et al 
1998 
112 87.500 79.917 to 
92.995 
49.58 DF 1 
Chung et al 2006 334 50.000 44.509 to 
55.491 
50.42 Significance level P < 0.0001 
Total (fixed 
effects) 
446 60.492 55.797 to 
65.048 
100.00 I2 (inconsistency) 98.32% 
Total (random 
effects) 
446 70.187 30.262 to 
97.240 
100.00 95% CI for I2 96.22 to 
99.25 
 
Primary graft patency 
Only four of the included studies reported on primary graft patency.  At 3 years follow up, only two 
studies reported primary graft patency with Nicoloff et al. reporting the highest percentage of 87.5% 
(68). The calculated pooled effect proportion using random-effects model among the two studies was 
70.2%; (95% CI 30.3 to 97.2; n = 446), with statistically significant heterogeneity (Cochran's Q test = 
Q = 59.4 on 1 degree of freedom, P <.0001, I2 = 98%).  Significant heterogeneity existed between the 
two studies (Figure 3b). 
Meta-­analysis
0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Proportion
Nicoloff  et  al    1998
Chung  et  al  2006
Total  (random  effects)
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Figure 3c: Forest plot of meta-analysis of the proportion estimates for post-operative outcome: 







95% CI Weight (
%) 
Test for heterogeneity 
Random Q 23.8936 
Abou-Zamzam et al 
1997 
513 79.922 76.190 to 
83.305 
35.31 DF 2 




P < 0.0001 







959 81.472 71.495 to 
89.699 




Only three of the included studies reported on ambulatory recovery at six months follow up (41, 43, 
68). Nicoloff et al reported the highest percentage of 92.0% (68). The calculated pooled effect 
proportion using random-effects model among the two studies was 81.5%; (95% CI 71.5 to 89.7; n = 
959), with statistically significant heterogeneity (Cochran's Q test = Q = 23.89 on 2 degree of 
freedom, P = <.0001, I2 = 92%). Figure 3c demonstrates considerable heterogeneity across the three 
studies.  
Meta-­analysis
0.6 0.7 0.8 0.9 1.0
Proportion
Abou-­Zamzam  et  al  1997
Nicoloff  et  al    1998
Chung  et  al  2006
Total  (random  effects)
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95% CI Weight (
%) 




Goshima et al 2004 318 54.088 48.437 to 
59.662 
33.28 DF 2 
Abou-Zamzam et al 
1997 




P < 0.0001 








1165 34.571 10.951 to 
63.280 




Wound healing among the patients was reported at six months of follow up by three studies. Goshima 
et al. (40) reported the highest percentage of wound healing among the study population at 54.0% while 
Abou-Zamzam et al. reported as low as 12.1% (43). The calculated pooled effect proportion using 
Meta-­analysis
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
Proportion
Goshima  et  al  2004
Abou-­Zamzam  et  al  1997
Chung  et  al  2006
Total  (random  effects)
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random-effects model among the three studies was 34.6%; (95% CI 11.0 to 63.3; n = 1165), with 
statistically significant heterogeneity (Cochran's Q test = Q = 200.99 on 2 degree of freedom, P <.0001, 
I2 = 99%). Considerable heterogeneity existed between the three studies (Figure 3d). 
 
DISCUSSION 
The literature search for the systematic review resulted in only six publications which met the eligibility 
criteria for our study. None of the publications studied patients’ pre-operative metabolic profile in detail 
to assess any association with post-operative outcome. The total sample size of the six eligible studies 
was 2,446 (Sample size range: 112-841patients) with a mean follow-up 40.5 months for four studies. 
In the remaining two studies, the duration of follow up was not stated. Five of the six studies were 
conducted retrospectively. Patients’ attrition rate was also poorly recorded except in one study. All six 
studies reported a combination of technical and functional outcomes. The combination of outcome 
variables varied among the studies and the timelines for outcome measures also varied widely. Of 
importance, five out of the six studies reported post-operative outcomes for only infrainguinal bypass; 
there was no inclusion of endovascular intervention or hybrid procedures. Goshima et al studied the 
outcomes after infrainguinal bypass surgery to determine risk factors for adverse outcomes. It was found 
that time to heal exceeded three months in >50% of patients and diabetes mellitus was a risk factor for 
prolong wound healing (19).  In a study by Taylor et al, clinical success was defined as achieving all 
the following criteria: graft patency to the point of wound healing; limb salvage at one year; 
maintenance of ambulatory status for one year; and survival at six months. Despite > 70% limb salvage 
and graft patency at three years, only 44.4% of the patients achieved the composite endpoint of clinical 
success as stated above (20). Predictors of failure were the presence of gangrene, ESRD, 
hyperlipidaemia and impaired pre-operative ambulatory function. Taylor et al again examined the 
determinants of functional outcome after revascularization for critical limb ischemia. Findings were 
that, at five years, graft patency and limb salvage were acceptable at 70%. Functionally, however, at 
five years’ survival was only 41% with 70% ambulatory recovery (21). The post-operative outcome 
was not influenced by the level of disease or type of operation. However, sub-optimal post-operative 
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CONCLUSION 
There is an enormous body of publication data on peripheral arterial disease. Most of the data however 
involve disease epidemiology, comparison of various treatment outcomes and experimental work on 
new treatment modalities. There is relatively little published data on metabolic profile and its impact 
on surgical treatment outcomes. This limits the effectiveness and quality of systematic review on that 
aspect of peripheral arterial disease research and accounts for the heterogeneity of the selected studies 
for the meta-analysis. That notwithstanding, using composite post-operative outcome measures for the 
evaluation of patients with CLI, many reports reveal that only a small proportion of patients with CLI 
who undergo surgical intervention attain full clinical success.  This reinforces the fact that the traditional 
reporting standard of technical outcome is inadequate to fully evaluate patients’ recovery post-
operative. It is required that studies conform to uniform reporting standards with respect to timelines to 
overcome the significant heterogeneity among the studies depicted above. The summary result should 
therefore be interpreted with some level of caution. Multiple factors may influence post-operative 
outcomes including patients’ metabolic profile. There is a desperate need to advocate for more 
prospective studies or even randomized trials with clearly delineated criteria for selection of participants 




1.   Small	  number	  of	  studies	  elligible	  for	  the	  meta-­‐‑analysis.	  This	  resulted	  in	  restricted	  analysis	  
and	  non-­‐‑comprehensive	  results.	  	  
2.   Recall	  and	  selection	  bias	  due	  to	  the	  large	  number	  of	  retrospective	  studies	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ABSTRACT 
 
Metabolic profile and post-operative outcomes in contemporary patients with peripheral arterial 
disease and critical limb ischaemia- an observational prospective cohort study 
 
Authors: Lily Wu, MBChB (GH), FWACS (GH), Cert Vascular Surgery (SA), Nadraj G. Naidoo, 
MBChB, FCS (SA), Department of Vascular and Endovascular Surgery, Groote Schuur Hospital, 
University of Cape Town, Cape Town, Republic of South Africa. 
 
Background: Peripheral arterial disease (PAD) is an established occlusive disease of the peripheral 
arteries and is not uncommon in the elderly.  Atherosclerosis accounts for 90% of the pathology. Only 
15% of affected individuals become symptomatic. Most symptomatic individuals present with 
intermittent claudication (IC). Only a small proportion (1%) of affected individuals present with 
critical limb ischaemia (CLI). Revascularization aimed at limb salvage, and recovery of ambulation 
and independent living is the ultimate therapeutic option for the advanced form of PAD (CLI). 
Traditionally, the success of revascularization for CLI has been defined by graft patency rates and 
limb salvage rates. Functional outcomes such as ischaemic wound healing and recovery of ambulatory 
function for independent living have been the focus in more recent publications. However, these 
assessments do not consider the patients’ pre-operative metabolic profile as a predictor of post-
operative outcomes. 
 
Purpose: The purpose of this study was to determine, in a prospective manner, the influence of pre-
operative metabolic profile on post-operative outcomes in contemporary patients with peripheral 
arterial disease presenting with critical limb ischaemia at a tertiary hospital in South Africa.  
 
Methods: All consecutive patients, ³18 years, with CLI admitted to the vascular unit at Groote Schuur 
Hospital over a two-year period (1st January, 2015 to 31st December, 2016) with reconstructable 
disease were recruited for the study. Written informed consent was obtained from all participants. 
Revascularization entailed either open surgical revascularization, endovascular interventions or both 
(hybrid procedures). Data was analyzed according to the clinical level of disease and the type of surgical 
intervention. Post-operative outcome measures were determined.  
 
Primary endpoints (functional and technical outcomes) 
•   Ambulatory recovery at six months and one year 
•   Complete ischaemic wound healing at six months and one year 
•   Limb salvage rate at six months and one year 
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•   Primary graft patency rate at six months and one year 
 
Secondary endpoint  
•   The influence of pre-operative metabolic profile on the post-operative outcomes  
The association between pre-operative metabolic profile and post-operative outcomes was determined 
by Pearson Chi-square statistical test and logistic regression model. 
 
Results: A total of 73 consecutive patients were recruited for this study with a mean age of 58 ± 9 years 
(Range: 30 - 75 years). Seventeen patients (23.3%) had rest pain and 56 (76.7%) had tissue loss [Minor 
tissue loss was 47 (64.4%) and major tissue loss was 9 (12.3%)]. Current smokers and previous smokers 
constituted 86% of the sample population with a male to female ratio of approximately 1:1. Our study 
population was generally overweight based on the BMI. There was high prevalence of abdominal 
obesity and high body fat for both males and females.  
Recovery of ambulatory status was 69% and 67% at six months and one year follow-up respectively. 
The rate of ischaemic wound healing at six months and one year was 48.2% and 75.0% respectively. 
Surgical site sepsis was the most common local wound complication. Limb salvage rate was 78% and 
79% at six months and one year respectively. Overall primary graft patency at six months was 69.0% 
but reduced to 60.0% at one year. Major amputation rate at one year was 21%. More than half of the 
patients who had major amputations presented to hospital late with major tissue loss (12.3% out of the 
21%) requiring such major amputations. The rest had progressive disease after the initial presentation 
and treatment. Most of the post-operative wound-related complications occurred among patients with 
diabetes. More diabetic patients had major amputations compared to non-diabetic patients (57.9% vs 
42.1%). One year amputation-free survival (AFS) was 69.9%. There were no statistically significant 
associations between metabolic profile of patients and post-operative clinical outcomes.  
 
Conclusion: Demographics, co-morbidities, and procedural details of our study population, reflected a 
relatively younger population with CLI. The profile of this contemporary vascular surgery patients is 
that of overweight, high abdominal obesity, and high prevalence of smoking among both gender. The 
technical and functional outcomes observed in this study are consistent with available western literature. 
Diabetes was associated with prolonged ischaemic wound healing, higher risk of major amputation and 
local wound complications. A statistically significant association was not found between patients’ 
metabolic profile and post-operative outcome but this could be due to the small sample size and short 













Peripheral arterial disease (PAD) is a chronic occlusive disease of the peripheral arteries in the body 
with specific reference to the lower limbs. Atherosclerosis accounts for 90% of the pathology. This 
leads to narrowing (stenosis) or occlusion of the arteries and decreased lower limb perfusion. The result 
is exertional ischaemia classically in the calf muscles termed intermittent claudication (IC). In very 
severe disease, the reduced blood and oxygen supply is unable to meet even the resting metabolic rate. 
Therefore ischaemic foot pain develops in the recumbent position, typically at night, and is, 
unfortunately, termed rest pain. Critical limb ischaemia (CLI) is defined as rest pain of more than two 
weeks duration not responding to analgesics, the presence of tissue loss (ischaemic foot ulcer or 
gangrene), an ankle pressure of <50mmHg and toe pressure of < 30mmHg, (1) . In the presence of tissue 
loss in the ipsilateral lower extremity, the ankle pressure and toe pressures have been revised, by 
consensus (TASC II document), to >70 mmHg and >50 mmHg respectively (2). 
The prevalence of PAD increases with increasing age (3). Therefore it is a problem worldwide due to 
increasing life expectancy globally. The prevalence is estimated at 12% among adults generally but up 
to 20% among those over the age of 70 years (4). The natural history of claudicants is essentially benign:  
approximately 75% of patients with IC either remain stable or actually experience symptom 
improvement due to metabolic, physiological and psychological adaptation.  Critical limb ischaemia on 
the other hand is associated with a far worse prognosis (5). The annual mortality for individuals with 
IC is 5% but this increases sharply to about 20% in six months for those with CLI. This poorer prognosis 
of CLI relative to IC was noted in a study where 25% of patients with CLI progressed to major limb 
amputation within one year, and 25% died of cardiovascular complications within one year (6).  
Clinically, affected individuals may be: 
•   Asymptomatic or  
•   Symptomatic (Intermittent claudication) or  
•    Complicated 
o   Erectile dysfunction 
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o   Acute limb ischaemia 
o   Critical limb ischaemia 
 
Peripheral arterial disease is a clinical manifestation of systemic atherosclerosis. Therefore individuals 
with PAD also have increased risk of cardiovascular disease and cerebrovascular disease. Low ankle-
brachial pressure index (ABI), a marker of the severity of PAD is also associated with increased 
cardiovascular mortality (7). Cardiac events alone accounts for a significant proportion of the mortality  
in patients with PAD (8), (9), (10). In addition to the high mortality experienced by people with CLI, 
there is also associated significant morbidity with respect to impaired ambulatory function and reduced 
quality of life (11),(12). The most significant morbidity associated with CLI is the high rate of limb loss 
(major amputations). In the case of patients with non-healing leg ulcer or gangrene, 25% of patients are 
cured, another 25% die from the disease, 30% end up with major amputation and 20% continue to 
experience symptoms of the disease one year following revascularisation (5).  
Optimum medical therapy (OMT), lifestyle modification (exercise therapy, smoking cessation 
strategies; weight loss) and optimization of co-morbidities, particularly cardiovascular disease is the 
mainstay of treatment of patients with PAD irrespective of the clinical presentation (3). The use of 
pharmacological agents (statins; anti-platelet agents and certain anti-hypertensive medications) to 
reduce the progression of atherosclerosis, to reduce the risk of cardiovascular and cerebrovascular 
events, and  improve survival and quality of life , is evidence-based and universally advocated. (13), 
(14), (14). Revascularization strategies, however, constitutes a significant component of the 
management of the advanced form of PAD (CLI). It is aimed primarily at limb salvage, but also to 
facilitate independent living.  
Both medical and surgical treatment for PAD impose a huge financial burden either on the state or 
affected individuals due to the protracted course of the disease. The psychological stress for both 
patients and caregivers is enormous. One of the ways to reduce this huge burden of disease is to pre-
operatively profile patients with PAD to determine any association with post-operative outcome with 
the aim of pre-operative patient optimisation to achieve improved post-operative outcomes. 
A metabolic profile refers to an individual’s physical/physiological wellbeing as assessed by 
anthropometric measurements and haematological and/or biochemical evaluation. It is a measure of 
one’s immune competence to withstand adverse events such as trauma, major surgery and infections. It 
is also a measure of the body’s capacity for wound healing. Surgical outcomes may be influenced by 
patients’ factors such as pre-operative metabolic profile, extent of disease and co-morbidities. Other 
predictive factors of surgical outcome may be the mode of operation (open surgical reconstruction, 
endovascular intervention or both). In spite of the high burden of disease (3), there is limited research 
data globally, particularly in Sub-Saharan Africa on the effects of patients’ pre-operative metabolic 
profile on post-operative outcome. This study objectively assessed the pre-operative metabolic profile 
of patients with CLI to determine any relationship with post-operative outcomes.  
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JUSTIFICATION OF THE STUDY 
The prevalence of peripheral arterial disease varies widely with age (13), (14). Generally it ranges from 
3% to10%, however for persons over 70 years it is between 15% and 20%,(3) . Thus, PAD prevalence 
clearly increases dramatically with age, (13), (14).  It is also known to disproportionately affect the 
black population (13), hence the relevance of this study in South Africa. The REduction in 
Atherothrombosis for Continued Health Registry (REACH) has revealed that there is under-treatment 
of PAD relative to coronary artery disease (CAD) or cerebrovascular disease (CBVD), (14).  
Majority of individuals with PAD have one or more cardiovascular disease risk factors with associated 
high morbidity and mortality. Pre-operative metabolic profile may play a significant role in the 
incidence of post-operative morbidity; particularly wound healing and major limb amputation rates. 
The aim of this study was to evaluate the influence of the pre-operative metabolic profiles of patients 
with CLI on post-operative morbidity and mortality. Findings from this study may influence patient 
selection to improve operative outcomes. It may also inform policy change regarding pre-operative 
patient optimization for surgery and thereby minimize post-operative morbidity and mortality. 
  
AIM 
To determine the influence of pre-operative metabolic profile on post-operative outcomes in 
contemporary vascular surgery patients with peripheral arterial disease presenting with critical limb 
ischaemia in a tertiary hospital in South Africa.  
 
OBJECTIVES 
1.   To determine the demographic characteristics of patients with CLI 
2.   To determine the risk factors and metabolic profiles of participants 
3.   To determine the clinic-pathological characteristics of CLI  
4.   To assess technical and functional post-operative outcomes  
5.   To determine any association between metabolic profiles and post-operative outcomes 
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PATIENTS AND METHODS 
Study design: An observational prospective cohort study, over a two-year period (1st January, 2015 to 
31st December, 2016) was conducted to assess the influence of pre-operative metabolic profile on post-
operative outcomes following revascularization for CLI in conventional risk patients. Consecutive 
eligible patients were recruited for this study. Follow up was for a period of one year. Data was collected 
manually using a datasheet and later processed digitally onto a Microsoft Excel spread sheet (2010 
software). The data was subsequently  abbreviated for statistical purposes and transferred to STATA 
version 14, for analysis. 
The information collected was kept confidential. The soft copy was secured on a computer with 
password  protection for access. The hard copy was kept secure in a locked cupboard in a protected 
office by the principal investigator. The data collected was not shared with or given to anyone else 
besides the researchers. Identity of participants was protected by the use of hospital numbers rather than 
actual patient names.  
This study was approved by the Departmental (Surgical) Research Committee and the Human Research 
Ethics Committee of the University of Cape Town.  
Setting: The study was carried out at the Vascular unit of Groote Schuur Hospital (GSH), Observatory, 
Cape Town. Groote Schuur Hospital is a tertiary hospital, the second largest hospital in South Africa, 
situated in the Western Cape.  
Study population: All conventional risk adult patients (³18 years old) with established PAD (critical 
limb ischaemia), and with reconstructable disease were recruited into the study. A written informed 
consent was obtained from all participants in this study.  
Inclusion criteria: 
l    Established PAD 
l   CLI with rest pain 
l    CLI with ischaemic foot or leg ulcer  
l   CLI with gangrene of the foot (salvageable foot) 
l   Revascularization for stump salvage (Patients requiring major amputation in the clinical 
context of  poor inflow or poor runoff) 
Exclusion criteria: 
l   High risk surgical patients not fit for revascularization 
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l   Patients with non-reconstructable disease on vascular imaging 
l   Patients who are unable to or who refuse to give informed consent 
l   Patients who are not independent 
l   Patients who are not ambulant (confined to a wheel-chair or bed-ridden) 
l   Patients who had previous revascularization 
Information collected included basic demographic details, basic haematological and biochemical tests 
results, comorbidities, presence or absence of rest pain or tissue loss, length of hospital stay, and both 
pre-operative and post-operative ambulatory status. Data was collected by personal interviews and also 
from review of patients’ hospital records. Patients pre-operative metabolic profiles were assessed using 
haematological and biochemical variables (haemoglobin, serum albumin, fasting plasma glucose, 
HbA1c). Anthropometric parameters  (BMI, WHR, TSFT, MUAC) were measured using only one and 
the same non-stretch tape measure, weighing scale and calliper. Anthropometric measurements were 
assessed using the WHO definitions and instructions for measurement, appendix 6,7 and 8. Indication 
for surgical intervention was categorized into rest pain and ischemic tissue loss. Ankle-brachial pressure 
index (ABI) and arterial colour duplex (DUS) scanning were done for all patients before operation and 
at each follow-up out-patient clinic visit at one month, three months, six months and one year after the 
operation to check for graft patency. CT angiogram (CTA) or diagnostic peripheral angiogram (DSA) 
was done as and when indicated. Routinely, duplex ultrasound was done on both lower limbs but 
treatment was limited to the clinically symptomatic limb.  
The type of surgical intervention (endovascular intervention, open surgical revascularization or hybrid 
procedure) was noted. Any additional operation and re-operations after the index revascularization 
procedure (minor/major amputation, wound debridement) were recorded. Local wound complications, 
time to wound healing, ambulatory recovery, level of amputation, limb salvage and primary graft 
patency were determined.  
 
Definitions: 
•   Wound healing assessment was by prevalence of local wound complications and by the 
proportion of ischaemic and surgical wounds which healed completely by six months and one 
year. 
•   Ambulatory status was irrespective of whether it was indoors or outdoors 
•   Major amputation referred to any amputation above the level of the ankle  (BKA, TKA, AKA, 
hip disarticulation).  
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•   Minor amputation  referred to any foot amputation not requiring a prosthesis to mobilize   
•   Limb salvage is defined as the absence of major amputation following revascularization 
•   Primary graft patency was determined at each OPD visit with DUS. Grafts were considered 
patent if the PSV was  < 180cm/s, velocity ratio <2, flow in the graft >45cm/s and ABI drop 
following exertion not > 15% 
•   Re-operation referred to repeat ischaemic foot ulcer debridement, debridement for  surgical site 
sepsis and minor foot amputation as a staged procedure following revascularization.  
•   Re-intervention referred to any repeat ipsilateral open surgical or endovascular procedure 
following revascularization for CLI.  
Regular post-operative scheduled clinic visits (one month, every three months for the first year, and 
every six months for the second year), was observed. Patients with complications were seen more 
frequently or re-admitted for further treatment when indicated. Additionally, patient follow-up was 
augmented with telephone calls directly to the patients or patients’ relatives in the case of deceased 
patients.  
Statistical consideration: 
Sample size: On average, 2 revascularization procedures (endovascular, open revascularization or 
hybrid procedure) are done per week, i.e. 8 cases in a month. Expected number of revascularization 
procedures in 2 years is 192. 
A sample size of 96 achieves 85% power to detect a difference of 0.30000 between the null 
hypothesis correlation of 0.00000 and the alternative hypothesis correlation of -0.30000 using a two-
sided hypothesis test with a significance level of 0.05000. 
Ho: There is no association between post-operative outcomes (dependent) variables and metabolic 
profile (independent variables). 
 
Ha: There is an association between post-operative outcomes (dependent) variables and metabolic 
profile (independent variables). 
 
Where Ho = Null hypothesis  
           Ha = Alternative hypothesis 
The significance level to reject the null hypothesis is set at 0.05 (α = 0.05) 
 
Data management and analysis:  
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Descriptive statistical analysis was conducted to describe the demographic and clinico-pathological 
characteristics of the study population. Continuous variables were presented as mean, standard 
deviation, box and whisker plot for normal distribution data. Categorical variables were presented as 
proportions, bar charts and pie charts. Median, interquartile range (IQR) and line graphs were used for 
skewed data.  
Functional and technical post-operative outcome measures were presented using actuarial life-table 
method (Kaplan-Meier analysis). Pearson Chi-square statistical test was conducted to determine the 
association between the independent and dependent variables. Logistic regression model was conducted 
to adjust for multiple confounders. Odd ratio, 95% confidence interval and P value <0.05 were used to 




The mean follow-up in our study was 9.9 months (Range: 3-22months), 73 patients were available for 
analysis, four patients were lost to follow up. The overall mean age of the study population was 58 ± 9 
years (Range: 30-75years). There were 36 (49.3%) females and 37 (50.7%) males(Table 1). The mean 
age at presentation was 60.9 years for females (Range: 34-75years) and 55.1 years for males (Range: 
30-70years), (p value < 0.01), (Fig 1). Table 2 shows the risk factor prevalence and co-morbidities of 
patients. Smoking was the most predominant risk factor in the study population with a prevalence of 
86.3% (current smokers and ex-smokers) and a male to female ratio of 1:1. Only 13.7% of the patients 
had never smoked. Table 3 shows the pattern of anti-diabetic and anti-hypertensive treatment. Less than 
50% of the patients were on statins at admission in this study. In contrast, the proportion of patients on 
aspirin at the time of admission was relatively high at 74.0%.  
 
Table 1: Clinical level of disease and gender distribution 
Clinical level of disease 
No. of patients Gender 
𝒏 (%) Male  𝒏 Female  𝒏 
Aorto-iliac disease 16 (21.9%) 10 6 
Fem-pop disease 48 (65.8%) 21 27 
Tibio-peroneal disease 9 (12.3%) 6 3 
Total  73 (100%) 37 36 
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Fig. 1 Age and gender distribution 
 
Table 2: Prevalence of risk factors and comorbidities 
 Clinical level of disease  
 Aorto-iliac Fem-pop 
Tibio-
peroneal Total 
 𝒏 (%) 𝒏 (%) 𝒏 (%) 𝒏 (%) 
Total Number of patients 
(𝒏	  =73) 
16(21.9%) 48(65.8%) 9(12.3%) 73(100%) 
Smokers  12(75.0%) 23(48.0%) 4(44.4%) 39(53.4%) 
Ex-smokers 2(12.5%) 20(41.7%) 2(22.2%) 24(32.9%) 
Diabetes 4 (25.0%) 35 (72.9%) 5(55.6%) 44 (59.5%) 
Hypertension 11(68.8%) 40(83.3%) 8(88.9%) 59(80.8%) 
Hypercholesterolemia 7 (43.8%) 25 (52.1%) 6(66.7%) 38 (52.1%) 
Cerebrovascular disease                          11(15.1%) 
Coronary artery disease    5(6.8%) 
Chronic kidney disease            2(2.7%) 
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Seventeen patients (23.3%) had rest pain and 56 (76.7%) had tissue loss [Minor tissue loss 47 (64.4%) 
and major tissue loss 9 (12.3%)], (Table 4). The average duration of symptoms was 13.7 ± 13 weeks 
(Range: 0.7 - 68.5 weeks) (Fig 2). Table 5 shows the TASC grading of disease profile. The mean ankle 
pressures and ABIs are shown in Table 6. Duplex ultrasound was the initial imaging modality in all 
patients (Fig 3). The patency of crural vessels assessed by imaging investigation revealed that 31.5% 
of the patients had only one crural vessel patent, 32.9% had two patent vessels, 24.7% had all three 
vessels patent and 10.9% had no patent crural arteries, fig 4.  
 
Table 4: Clinical level of disease: Rutherford clinical category 
Clinical level of disease 
Rutherford category 
4 (rest pain) 5 (minor tissue loss) 
6 (major tissue loss 
requiring a major 
amputation) 
Aorto-iliac disease 6 (37.5%) 10 (62.5%) 0 (0%) 
Fem-pop disease 11 (22.9%) 29 (60.4%) 8 (16.7%) 
Tibio-peroneal disease 0 (0%) 8 (88.9%) 1 (11.1%) 
Total  17(23.3%) 47(64.4%) 9(12.3%) 
 
 
Diabetic patients  𝒏 %       
Oral hypoglycemic agent  27 61.36 
Insulin   6 13.64 
Both  11 25 
Total 44 100 
Hypertensive patients 𝒏 %       
Single Agent  15 25.42 
2 or more agents  44 74.58 
Total 59 100 
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Fig. 2 Duration of symptoms of disease 
 
Table 5: Clinical levels of disease: TASC grading 
Clinical level of disease 
TASC grade 
A B C D 
Aorto-iliac disease 0 (0%) 1 (6.2%) 7 (43.8%) 8 (50%) 
Fem-pop disease 3 (5.3%) 16 (33.3%) 25 (52.1%) 4 (8.3%) 
Tibio-peroneal disease 1 (11.1%) 1 (11.1%) 6 (66.7%) 1 (11.1%) 
Total  4(5.4%) 18(24.7%) 38(52.1%) 13(17.8%) 
 
Table 6: Clinical level of disease: Ankle pressures and ankle brachial pressure index (ABI) 
Clinical level of disease 
Ankle pressures 
𝒏 𝐱 SD Min Max 
Aorto-iliac disease 16.0 26.6 33.5 0.0 100.0 
Fem-pop 48.0 71.1 67.1 0.0 260.0 
Tibio-peroneal 9.0 131.7 61.5 60.0 260.0 
 Ankle brachial pressure index (ABI) 
Aorto-iliac disease 16.0 0.18 0.22 0.00 0.50 
Fem-pop 48.0 0.47 0.40 0.00 1.50 
Tibio-peroneal 9.0 0.68 0.36 0.38 1.50 
 
Page	   52	  
 
Fig. 3 Pre-operative imaging modalities 
 
 
Fig. 4  Number of patent crural arteries  
 
Metabolic profile 
The anthropometric, haematological/biochemical measurement are shown in tables 7 and 8. The overall 
mean body mass index (BMI) was 26.04. Twenty four (32.8%) patients had BMI >25.0 and thirteen 
(17.8%) patients had BMI >30.0. The mean waist: hip ratio (WHR) was 0.96, (0.99 for males and 0.93 
for females). The overall mean haemoglobin level was 12.5g/dl (SD 2.5, min. 6.1, max. 18.5). The mean 
for males and females were 13.2 g/dL and 14.2 g/dL respectively. There were two patients with 
confirmed diagnosis of chronic renal  disease but only one patient had a creatinine of >120 µmol/L on 
admission. The mean serum albumin was 3.8 g/L (SD 5.8, min. 2.8, max. 5.1). Forty-four patients were 
known with diabetes. Two (6.9%) out of the 29 patients who were not previously diagnosed with 
diabetes had a HbA1c > 10% (newly diagnosed diabetes on admission). Average fasting plasma glucose 
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Page	   53	  
Table 7: Anthropometric measurements  
 n 𝐱 SD min max 
Parameters Males 
BMI- (kg/m2) 37 24.98 4.27 16.85 34.52 














BMI- (kg/m2) 35 27.16 7.26 17.31 45.96 
WHR 35 0.93 0.16 0.09 1.12 
TSF-mm 36 12.75 4.80 3.90 25.00 
MUAC-(cm) 35 28.46 5.02 21.00 43.00 
 Whole group 
BMI - (kg/m2) 72 26.04 5.97 16.85 45.96 
WHR 70 0.96 0.13 0.09 1.16 
TSFT-(mm) 69 12.66 4.41 3.90 25.00 
MUAC-(cm) 70 28.47 4.34 20.00 43.00 
 
 
BMI                         Body mass index 
WHR                       Waist-hip circumference ratio 
TSFT                       Triceps skin fold thickness 
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Table 8: Haematological and biochemical parameters 
Parameters n 𝐱 SD min Max 
Haemoglobin (g/dl) 73 12.5 2.5 6.1 18.5 
White cell count(x109/L)                                 73 11.2 3.5 6.1 24.7 
Platelet count (x109/L) 73 389.9 150.1 156.0 963.0 
INR 73 1.08 0.14 0.85 1.9 
Serum creatinine (µmol/L) 67 72.9 23.0 32.0 187.0 
Serum albumin(g/L) 67 3.8 5.8 2.8 5.1 
Fasting plasma glucose (group)( mmol/L) 68 7.8 3.0 3.0 15.6 
Fasting plasma glucose (DM only) ( 
mmol/L) 
41 8.9 3.2 3.0 15.6 
HbA1c (DM only) 41 8.8 2.3 4.3 13.5 
HbA1c (non-DM only) 23 6.0 1.4 5.0 10.8 
 
 Treatment outcomes  
A third of the study population (31.5%) had endovascular interventions, 58.9% had open 
revascularization (autologous vein 41.9% and prosthetic grafts 58.1%) and 9.6% had hybrid procedures, 
(Fig 5). Surgical site sepsis was the most common surgical wound complication (Table 9). There were 
two (4.7%) cases of early graft sepsis, (both were PTFE grafts) and two (4.0%) cases of early graft 
occlusion (PTFE graft). Fifty-six patients had ischaemic wounds and 36 of them were known with 
diabetes mellitus (Fig. 13). Only 48.2% of the ischaemic wounds healed by six months. At one year 
follow up 75% of the ischaemic wounds had healed (Fig 13). Thirteen diabetic patients and five non-
diabetic patients had septic ischaemic wounds at admission. Out of the 12 cases of surgical site sepsis, 
10 occurred in diabetic patients compared to two in non-diabetic patients(Table 9).  
Mean length of hospital stay was 17.5 days (SD: 17.7, Range: 3 days to 110 days). Table 10 a and Table 
10b show some of the results of test of association of the patients’ metabolic profile and post-operative 
outcomes. The presence of co-morbidities such as cerebrovascular disease, coronary artery disease and 
chronic kidney disease was not found to be associated with post-operative outcome. This may be due 
to the small number of patients with such co-morbidities in our study. 
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Fig. 5 Type of surgical intervention 
 
Table 9: Early post-operative complications 






Hybrid procedure 𝐧(%) 
Surgical site sepsis     9 (20.9%) 0 (0%) 3 (42.9%) 
Seroma/Haematoma   2 (4.7%) 1 (4.3%) 0 (0%) 
False aneurysm   1 (2.3%) 0 (0%) 0 (0%) 
Graft sepsis   2 (4.7%) 0 (0%) 0 (0%) 
Graft occlusion   1 (2.3%) 0 (0%) 1 (14.3%) 
Total   15 (34.9%) 1 (4.3%) 4 (57.2%) 
 
 
Number of patients who had open revascularization = 43 
Number of patients who had endovascular intervention = 23 








Open	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Table 10a: Test of association between metabolic profiles and post-operative outcomes at 6 months 
Dependent variables 
(Metabolic profile 
parameters combined with 
post-operative outcome. 




Odd’s ratio 95% confidence 
interval 
p-value 
BMI< 25 0.66 0.16 to 2.46 0.49 
WHR <0.9 0.27 0.05 to 1.50 0.06 
TSFT <11 1.70 0.44 to 7.28 0.39 
MUAC<26 3.2 0.58 to 32.74 0.14 
Hb<10g/dl 2.11 0.36 to 22.18 0.37 
Fasting plasma glucose <6.1 1.11 0.27 to 4.27 0.86 
HbA1c <7 1.20 0.32 to 4.65 0.76 
Albumin<3,5 0.94 0.23 to 4.24 0.93 
 
 
Table 10b: Test of association between metabolic profiles and post-operative outcomes at 6 months 
Dependent variables 
(Metabolic profile 
parameters combined with 
post-operative outcome. 




Odd’s ratio 95% confidence 
interval 
p-value 
BMI>25 0.46 0.10 to 1.76 0.21 
WHR >0.9 0.46 0.09 to 2.76 0.29 
TSFT >16.5 1.29 0.19 to 14.39 0.77 
MUAC>29 0.59 0.16 to 2.17 0.37 
Hb>10g/dl 2.11 0.36 to 22.18 0.37 
Fasting plasma glucose >6.1 1.11 0.27 to 4.27 0.86 
HbA1c >7 0.59 0.15 to 2.23 0.38 
Albumin>3.5 0.63 0.16 to 2.67 0.46 
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DISCUSSION 
Our study population was predominantly middle-aged with a male to female ratio of 1:1. Females 
presented at a significantly older age than men (p value < 0.01). More than half (50.6%) of our study 
population was either overweight or obese. Smoking was the predominant risk factor for atherosclerosis 
with equal prevalence among males and females. The high number of females affected may be 
explained by the high prevalence of smoking among females (77.8%). Patients generally presented to 
hospital after ten weeks from the start of symptoms usually with a more advanced clinical presentation. 
The age of patients in our study population is lower than that in existing Western literature, (2), (11), 
(15), (16), (17). The male to female ratio in our study also differs significantly from the 3:1 ratio 
reported in existing Western literature (15), but similar to findings in a study in Uganda, (18). Similar 
to other reports, there were more patients with tissue loss in our study than rest pain only, (19), (20), 
(21). The pattern and distribution of occlusive disease is consistent with the study by Taylor et al, with 
more infra-inguinal disease than aorto-iliac disease (22). The small number of patients with TP disease 
may be due to selection bias for intervention. Most of our patients with isolated TP disease have poor 
runoff and very calcified vessels precluding them from revascularization. It is acknowledged however, 
that there are some publications that show good post-operative outcomes following revascularization 
for patients with isolated TP disease and tissue loss, (3). The overall mean duration of symptoms of 13 
weeks is longer than was found by Bailey et al. in a one-year prospective study, (23). The much longer 
duration of symptoms for TP disease compared to the other clinical levels of disease may be explained 
by the least amount of ischaemic tissue due to the distal location of the occlusive disease (Fig 2). More 
than 50% (five out of a total of nine) of the patients with TP disease were confirmed to have diabetes 
mellitus. Diabetic peripheral neuropathy, poor socio-economic circumstances and travel issues may also 
account for the delay in clinical presentation in this group.  
The pattern of pre-operative ankle pressures and ABI for the various clinical levels of disease, shown 
in Figures 6 and 7, is consistent with the existing literature. The high ankle pressures and ABI among 
the patients with TP disease could be due to the high prevalence of diabetes (55.6%) among such 
patients with associated calcified non-compressible crural arteries (medial calcinosis).  
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Fig. 6 Pre-operative ankle pressure by clinical level of disease 
 
 
Fig. 7 Pre-operative ABI by clinical level of disease 
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Patients who had endovascular intervention had higher pre-operative ABIs than those who had open 
reconstruction or hybrid procedure, (Fig.8). This is suggestive of less severe disease among patients 
who had endovascular intervention and is in agreement with the TASC recommendation. The post-
operative increase in ABI followed a similar trend,  (Fig 9). The increase in ABI in the immediate post-
operative period was sustained up to one year, (Fig 10). Eleven percent of the patients had no patent 
runoff vessels but had revascularization as an inflow procedure for stump salvage (Fig 4). 
 
 
Fig. 8 Pre-operative ABI by the type of operation  
 
 
Fig. 9 Post-operative ABI by the type of operation 
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Fig. 10 ABI trend from pre-operative to post-operative period 
 
The prevalence of risk factors for atherosclerosis, in our study population, is consistent with existing 
Western literature with smoking being the most prevalent risk factor (86.3%) (Table 2), (3), (22), (23). 
All our hypertensive patients were on some form of anti-hypertensive treatment. A significant number 
of them (74.58%), however, were on 2 or more agents. Ten (16.9%) patients had poorly controlled BP 
(Normal BP defined as <140/90mmHg). The low level of statin medication (47.97%) in our study 
population at baseline is consistent with findings in other studies like the PREVENT III study where 
only 46% of the participants were on lipid lowering medication (24), (25), (26). In contrast however, a 
larger proportion of our patients were on antiplatelet therapy (aspirin) compared to that in the 
PREVENT III study (74.0% vs 67%). This may be due to the high percentage of patients with 
hypertension among our study population. Most of such patients were started on aspirin (74%) in 
addition to anti-hypertensive medications (80.8%) by the general practitioner prior to referral to the 
vascular surgeon, (Table 3) (24). The prevalence of cardiovascular co-morbidities, particularly 
symptomatic CAD, is relatively low among our study population compared with other reports, (Table 
2), (18), (24), (27). This may be due to the relatively younger age of our study population. 
 
Metabolic profile  
BMI is a measure of body size and composition. It is used to diagnose underweight, overweight or 
obesity. However, alternative measures that reflect abdominal adiposity like WHR, have been suggested 
as being superior to BMI in predicting CVD risk. Increased visceral fat is associated with metabolic 
abnormalities viz. impaired glucose tolerance, reduced insulin sensitivity and adverse lipid profiles. 
These are risk factors for type 2 diabetes and CVD. Overall, our study population was overweight with 
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a mean BMI of 26.0, (Table 7), (3), appendix 6. Both males and females in our study have abdominal 
obesity according to the WHO definition, (Table 7; Appendix 7).  
Table 8 shows that the patients with diabetes have poor glycaemic control (Optimal glycaemic control 
defined as HbA1c of ≤7%), similar to findings in a study in Uganda,(23). 
 
Outcome measures  
In our study, open surgical revascularization was the predominant surgical intervention similar to the 
study by Bailey et al. and Taylor et al. but  at variance with recent studies where endovascular 
intervention is the most frequent surgical treatment (24), (25).  
Traditionally, the reporting standards for success of lower limb revascularization for CLI is as published 
by Rutherford et al. (28), (29). This is hinged on technical outcome measures of limb salvage, graft 
patency and survival. Subsequently, many recent publications including that by Taylor et al suggested 
that functional outcome measures, such as wound healing, recovery of ambulatory status, and 
amputation free survival are better outcome measures for assessing clinical success,(30), (23), (27), 
(24), (31). Using composite endpoints (technical and functional outcome measures) for the evaluation 
of post-operative outcomes revealed that only a small proportion of patients with CLI who undergo 
surgical intervention attain full clinical success (29). 
In our study, post–operative outcome was assessed by both technical (surgeon-oriented) measures such 
as limb salvage and primary graft patency and functional (patient-oriented) measures such as local 
wound complication rate, ambulatory recovery, mortality rate and minor/major amputation rates. At 
one year follow up in our study, ambulatory recovery was 67%, primary graft patency was 60% and 
limb salvage was 79%, (Fig. 11). One year primary graft patency rate of 60% to 80% and limb salvage 
rates of 70% to 90% have consistently been reported after treatment of CLI and is consistent with 
findings in our study (32). Pre-operative ambulatory status predicted post-operative ambulatory 
recovery, similar to the findings in other studies (33), (34).  
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Fig. 11 Trend of post-operative outcomes 
 
The overall one year major amputation rate of 21% in our study is similar to the 23.2% found in the 
study by Nicoloff et al. and in TASC II, (22), (35). In this study we included conventional risk patients 
with PAD and CLI requiring revascularization for stump salvage (Requiring a major amputation 
anyway). Less than 50% of ischaemic wounds healed at six months in our study population. Diabetic 
patients experienced more ischaemic wound sepsis and surgical site sepsis than non-diabetic patients 
(29.5% vs 17.2%) and (83.3% vs 16.7%) respectively. Overall early graft sepsis rate was 4.7% and 
early graft occlusion rate was 4.0%. The graft occlusion rate is comparable to findings by Goshima et 
al, with a 30 day graft occlusion rate of 3.1%, (36). More diabetic patients in our study had major 
amputations than non-diabetic patients (57.9% vs 42.1%), (34), (37). The overall surgical site sepsis 
rate was 24.0% and occurred among patients treated with open revascularization and hybrid procedure 
but none among the endovascular intervention group, (table 9). The Kaplan-Meier curves below (fig. 
12) show the survival trends of patients post re-operations, minor amputations and major amputations. 
Patients survival is highest when they had minor amputation and open revascularization compared to 
endovascular intervention and hybrid procedure. This may be due to the fact that, open surgery is more 
durable and coupled with minor amputation, patients are more likely to have uneventful post-operative 








1mth	   6mth 1yr
Chart	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AMBULATORY	  RECOVERY PRIMARY	  GRAFT	  PATENCY	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MAJOR	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  (SMA,	  BKA,	  AKA)	  RATES LIMB	  SALVAGE	  RATES
ISCHAEMIC	  WOUND	  HEALING	  RATE





Fig. 12 Survival trend post-operative (Kaplan-Meier curve)  
 
There was no peri-operative or 30- day mortality in our study, same as in the publication by Ambler et 
al, (21) but different from findings in many other studies, (25),(2),(21). At the end of one year follow 
up, six (8.2%) patients had died (one patient from urosepsis following inadvertent right ureteric injury, 
another patient from intestinal failure secondary to chronic mesenteric ischaemia and the remaining 
four deaths from unconfirmed causes). Majority of the mortality recorded (66.7%) occurred in patients 
with tissue loss, (28). One year amputation-free survival (AFS), defined as freedom from major 
amputation and all-cause  mortality was 69.9% in our study.  
The mean length of hospital stay (LOS) was 17 days in our study. This is comparable to the findings 
in a study in Germany (using data from the largest public health insurance in Germany) where the 
length of hospital stay varied from 11days to 22.1 days for Rutherford 4 to 6 disease, (28) and also in 
the study by Gibbons et al. (18) but higher than in some other reports, (38), (22).   
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Fig. 13 Pattern of ischaemic and surgical wound healing post-operative 
 
Association between metabolic profile and post-operative outcome 
We do have enough evidence to accept the null hypothesis. Therefore, we can conclude that there is no 
association between all metabolic profiles measured at baseline of the study (BMI, WHR, TSFT, 
MAUC, Hb, fasting plasma glucose, HbA1c) and outcomes of ischaemic wound healing and ambulatory 
recovery at 6 months among the patients followed with lower limbs ischemia. Tables 10a and 10b show 
that all the odd ratios, p-values and 95% confidence intervals are not statistically significant. We do 
acknowledge that this preliminary study report has a small sample size.  
Demographic characteristics and patient comorbidities were not included in the model for determination 
of association. This pilot study has provided many invaluable lessons which we hope to apply in a much 
larger prospective study to be conducted at this institution. A more robust multivariate analysis will be 
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CONCLUSION 
Demographics, co-morbidities, and procedural details of our study population reflected a relatively 
younger population with CLI. The rest of the profiles of patients depicted in this study is that of heavy 
smoking, abdominal obesity, overweight and high prevalence of hypertension. The post-operative 
outcomes in our study are similar to existing literature. Pre-operative ambulatory status is a predictor 
of post-operative ambulatory recovery. Diabetes is associated with more local wound complications 
and higher risk of major amputation. The rest of the metabolic profile factors did not reach statistical 
significance in predicting post-operative outcome. This may be due to a small sample size and short 
follow-up period.  
 
LIMITATIONS  
1.   Small sample size 
2.   No validation of tools used for the anthropometric measurements  
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Appendix 1: Patient consent form  
 
Consent Form for Participation in a Research Study 
(023/2016) 
Name  of  Researcher(s) 
Dr.	  Nadraj	  Naidoo	  (Principal	  Investigator)	  
Email:	  nadraj.naidoo@uct.ac.za	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Cell:083	  262	  8651	  
E22	  Vascular	  Lab	  Groote	  Schuur	  Hospital	  Ext	  3324	  
	  
Dr.	  LILY	  WU	  (Co-­‐Investigator)	  
Email:	  wxxlil001@myuct.ac.za	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Cell:072	  958	  7650	  
 
Title  of  study   
Metabolic profile and post-operative outcomes in contemporary 
patients with peripheral arterial disease and critical limb ischaemia 
 
Please read and complete this form carefully.  If you are willing to participate in 
this study, circle the appropriate responses and sign and date the declaration at 
the end.  If you do not understand anything and would like more information, 
please ask me (Dr. LILY WU). 
 
•   I have had the research satisfactorily explained to me in 
verbal and / or written form (Synopsis) by the researcher. YES / NO 
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•   I understand that the research will involve review of my 
clinical records with collection of information relating to 
the treatment of my illness. As part of routine clinical 
follow-up for two years, I may undergo an ultra-sound/CT 
scan and the results will be used as part of the study. YES / NO 
•   I understand that I may decide not to take part in this 
study or may withdraw from this study at any time without 
having to give an explanation.  This will not affect my care 
or treatment. YES / NO 
•   I understand that all information about me will be treated 
in strict confidence. My identity will be protected by 
replacing my name with a code and that I will not be 
named in any written work arising from this study. YES / NO 
•   I understand that you will be discussing the progress of 
your research with others at Groote Schuur 
Hospital/University of Cape Town. YES / NO 
 
I freely give my consent to participate in this research and have been given a copy 
of this form for my own information. 
 
 
Name of Participant   Signature        Date 
 
 
Name of Researcher        Signature        Date   
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You may contact the Human Research Ethics Committee if you have any ethical 
concerns or questions about your rights or welfare as a participant in this research. 
Kindly find contact details below. 
 
Human Research Ethics Committee 
Room E52 – 24 Old Main Building 




Tel: (021) 406 6492 
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Appendix 2: Data collection sheet  
Metabolic profile and post-operative outcomes in 
contemporary patients with peripheral arterial disease and 







Attach Patient Sticker 
 




  Sex   Male   Female 
   
Race  Asian  Black  Coloured White 
   
 
 
Phone number  Home 
   Mobile 
   Next-of-kin 
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Date of admission 
 
Clinical Data 
Risk Factors    
                           Hypertension  Yes  No 
 
    Diabetes Mellitus  Yes  No 
Type 1              Type 2   
 
                                                 On insulin or oral hypoglycaemic agent or both 
 
    Dyslipidaemia  Yes  No 
 
    Smoking history Smoker Ex-Smoker Non-smoker 
 
    Cardiovascular disease  Yes  No 
Angina MI    CCF  Other 
 
    Renal disease (CKD)   Yes  No 
 
    Cerebrovascular  Yes  No 
                                                                    Stroke  TIA 
 
Rutherford Category          4        5                         6 
            Rest Pain    Minor Tissue Loss Major Tissue Loss 
 
If Rutherford Category 4, 
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  Visual analogue score 
 
     
 
If Rutherford Category 5 or 6, 
 
Duration of ischaemic wounds 
 
Previous Peripheral Arterial Disease Intervention on the same leg 
       Yes                    No 
 
Activity of daily living (ADL) 
Ambulant                          Yes          No 
Independent                      Yes          No 
Active                                 Yes                     No 
 
 
Quality of life (VascuQoL-6) score   
 
 
Medication  Anticoagulation/antiplatelet Yes                       No 
    
    
Anti-hypertension               Yes                       No 
      






















Waist circumference (midpoint between the lower margin of the least palpable rib and the 
top of the iliac crest, at the end of expiration)                        
 
Hip circumference (Widest portion of the buttocks)       
 
WHR       
 
Does abdominal skin fold/apron hang over the groin (by visual inspection) with patient in 




Triceps skin fold thickness 
 
Level of disease 
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Buerger’s test  Positive Negative    
 
Tissue loss  Yes    No 
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Laboratory Data 
Haemoglobin 











Ankle pressures DP  
                                    PT 
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Ultrasound measure of depth of skin to CFA in the relevant groin   
 
Duplex      Yes   No 
CT Angiogram     Yes   No 
Digital subtraction angiography (DSA)   Yes   No  
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Appendix 2b: 
Intervention Data Capture Sheet 
 
Attach Patient Sticker 
 




 Graft used               Vein              Prosthesis 
 Prosthesis used                       Dacron            PTFE 
Vein used    RSVG  NRSVG  
 Spliced vein                            Arm                GSV                 Arm + GSV 
  
 Proximal anastomosis 
 
 Distal anastomosis 
 




Site CIA    EIA CFA     SFA Popliteal    ATA   Peroneal artery    PTA 
 
 Angioplasty   Yes    No 
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Technical Success  Yes    No 
 




Outcome  Death   Failure   Success 
 
Physical examination – Pulse status post- intervention (mark relevant) 
 
Ankle pressures DP 
                                    PT 
 
Ankle brachial index 
 
Duplex post-intervention    Yes   No 
CT Angiogram post-intervention   Yes   No 
DSA post-intervention     Yes   No 
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Discharge Data Capture Sheet 
 
Attach Patient Sticker 
 
Date of discharge 
 
Outcome/ Mortality 
   Alive    Dead 
 
Amputation  Nil      Toe     TMA        SMA      BKA AKA 
 
Time from initial intervention to amputation: 
 
Any re-operation on the limb  Yes   No 
   Specify if yes: 
 
 
Morbidity (If yes, please encircle relevant one in following list)     
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Graft sepsis 
    
If yes time of occurrence after operation (DURATION) 
 
 
Cardiac    Yes   No 
                             (Myocardial infarction, acute coronary syndrome, arrhythmia) 
 
Neurological    Yes   No 
                            (Stroke, transient ischaemic attack (TIA), amaurosis fugax) 
 
Lung     Yes   No 
                   (Infection, pneumonia, pulmonary embolism, pneumothorax, requirement for ventilation, 
tracheostomy) 
 
Leg     Yes   No 
                             (DVT, cellulitis) 
 
Urological    Yes   No 
                             (Urinary retention, urine infection, ARF) 
 
Bowel     Yes   No 
                             (Bleeding, obstruction, ischaemia) 
 
Rest pain if Category 4 Rutherford 
 
Relief of rest pain   Yes No 
Visual analogue score 
 
 
Wound healing if Category 5&6 Rutherford    
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Ischaemic wounds  Healed                   
                                                Present 
If healed, specify when wound(s) healed: 
 
Surgical wounds  Healed   
                                                Present 
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Appendix 2d: 
Follow-up data capture sheet 
 
Attach Patient Sticker 
 
 Intervention (state the surgical intervention patient had) 
 
Duration since intervention 
 
Outcome   Alive    Dead 
 
Amputation  Nil      Toe     TMA        SMA      BKA AKA  
Time from initial intervention to amputation: 
 
Any re-operation on the limb since last visit Yes   No 
   Specify if yes: 
 
 
Time from initial intervention to re-operation: 
 
Acute Coronary Syndrome since last visit  Yes   No 
Stroke/TIA since last visit    Yes   No 
Re-admission since last visit              Yes   No 
Date of re-admission 
Specify reason if yes: 
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Quality of life (VascuQoL-6) score   
 
Rest pain if Category 4 Rutherford 
 
Relief of rest pain         Yes               No 
 
Visual analogue score 
 
 
Wound healing if Category 5&6 Rutherford    
 
Ischaemic wounds Healed  
                                    Present 
If healed, specify when wound(s) healed: 
 
Surgical wounds Healed     
                                    Present 
If healed, specify when wound(s) healed: 
 
Ankle pressures     DP PT   
Ankle brachial index 
 
Duplex      Yes   No 
CT Angiogram     Yes   No 
Digital subtraction angiography (DSA)   Yes   No 
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If previous vein graft,  
                                    Primary graft patency  Yes  No 
   Assisted primary patency  Yes  No 
Secondary graft patency  Yes  No 
   Need for further intervention Yes  No 
 
If previous prosthetic graft,  
                                    Primary graft patency             Yes  No 
   Secondary graft patency             Yes  No 
   Need for further intervention          Yes  No 
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Appendix 3: Departmental Research Committee approval
“OUR MISSION is to be an outstanding teaching and research university, 
educating for life and addressing the challenges facing our society.” 
  UNIVERSITY OF CAPE TOWN 
Department of Surgery 
Departmental Research Committee 
Dr Timothy Pennel 
3rd Floor, Christiaan Barnard Building, Medical School  
Anzio Road, Observatory 7925, South Africa 
      Tel (021) 406 6476
Email:  tim.pennel@uct.ac.za  
Email: warda.brown@uct.ac.za 
Dr L Wu 
Department of Surgery 
Division of General Surgery 
Groote Schuur Hospital 
University of Cape Town 
Dear Dr Wu, 
RE:  PROJECT 2015/055 
PROJECT TITLE: Metabolic profile and post-operative outcome amongst 
patients with critical limb Ischamia 
The above proposal was reviewed by the Department of Surgery Research Committee and I am pleased 
to inform you that the committee approved the study. 
Please use the above project number in all future correspondence. 
Yours sincerely 
DR T PENNEL 
CHAIRMAN: RESEARCH COMMITTEE
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Appendix 4: Human Research Ethics Committee approval 
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Appendix 5: Patient information document 
 
Patient Information Document 
Participation in the following study 
Metabolic profile and post-operative outcomes in contemporary patients 
with peripheral arterial disease and critical limb ischaemia 
My name is LILY WU, a fellow in the Vascular Unit of Groote Schuur Hospital. 
I am conducting the above research in collaboration with the vascular unit as part 
of the requirements for my training for an MPhil in Vascular surgery.  
 
Purpose of the research 
Critical limb ischaemia is when you have pain in your leg with a non-healing 
wound or gangrene (a portion of the leg/foot dies) because of lack of blood flow 
to your leg. This study is to investigate any association between the nutritional 
status (metabolic profile) of adult patients with critical limb ischaemia and their 
post-operative outcomes. Some of the measurements and laboratory tests to be 
used in assessing the nutritional status/ metabolic profile include body weight, 
height, BMI, hemoglobin level, blood protein/ albumin level etc. 
Research data on this subject is scanty locally. Besides, this specific topic has not 
been comprehensively studied worldwide. Findings from this study may 
influence patient selection with respect to expected outcomes. It may also inform 
policy change regarding pre-operative patient optimization for surgery and 
thereby minimize post-operative morbidity and mortality. 
 
Participant selection 
All patients above 18 years with critical limb ischaemia who are treated in this 
hospital over a 2-year period will be kindly invited to take part in this study by 
willfully signing a consent form whiles on admission at the Vascular Ward (F16). 
We therefor invite you to take part in this study. 
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Voluntary Participation (Right to Refuse or Withdraw) 
Your participation in this research is entirely voluntary. It is your choice whether 
to participate or not. Whether you choose to participate or not, you will receive 
the same treatment that you require for your sickness. In other words, if you 
decide not to take part in this study, that decision will not negatively affect your 
treatment. You may also change your mind later and withdraw your 
participation in this study even if you agreed earlier. Deciding later to stop 
participating in this study will also not negatively affect your treatment. 
 
Procedures and Protocol 
During the research period (2years), information about yourself, certain physical 
measurements (body weight, height, BMI), the operation you will undergo and 
any complications that may occur will be recorded. You are not compelled to 
give your consent to take part in this study. Before you decide, you can talk to 
anyone you feel comfortable with about the research. You are more than welcome 
to stop me as I go through the information document to explain to you any word(s) 
that you may not understand. If you have questions later, you can ask me or the 
other staff on the ward.  
After the operation, you will be required to visit the clinic on a number of 
occasions (follow up) as part of our usual appointment schedule for patients 
treated for the same kind of illness as you have. There will be no additional 
clinic visit due to participation in this research. This will be at 1, 3 and six 
months, and at 1 and 2 years and further information will be recorded during that 
time concerning how well your wounds are healing or otherwise. Any limb 
amputation or death will also be recorded. 
Should you not be able to make it to the clinic, we will reach you telephonically 
to follow up. Each call will last about 5 minutes. 
Risks and Side Effects 
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This research only observes what happens to the patients with critical limb 
ischaemia. There is no use of a trial drug or device or new surgical technique. 
Therefore, there is nothing new that will be done to you in this research that 
may be a threat to your limb or life. 
Confidentiality 
We will not disclose the identity of participants in this research. The information 
that we collect will be kept confidential. You will be assigned a special code. The 
code will be used in place of your name for the purposes of this research. 
Information collected during the research will be put away in a secure facility and 
only the researchers will have access to it. We will lock that information up with 
a lock and key. It will not be shared with or given to anyone else besides the 
researchers. 
Sharing the Results 
The knowledge that we get from doing this research will be shared with you 
before it is made available to the public. Confidential information will not be 
shared. We will publish the results in order that other interested persons may learn 
from our research. 
Who to Contact 
If you have any questions you may ask them now or later, even after the study 
has started. If you wish to ask questions later, you may contact me via any of the 
following: Lily Wu, telephone # 072 958 7650, speed dial 77337, email 
wxxlil001@myuct.ac.za. 
This proposal has been reviewed and approved by department of Surgery 
Research Ethics Committee at Groote Schuur Hospital, which is a committee 
responsible for making sure that research participants are protected from harm.  
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Appendix 6: WHO categorization of BMI 
Classification  of  obesity  -­  Wikipedia  
https://en.wikipedia.org/wiki/Classification_of_obesity  
 
BMI (kg/m2) Classification 
< 18.5  underweight 
18.5–24.9  normal weight 
25.0–29.9  overweight 
³30.0 obesity 
 
Appendix 7: WHO definition of abdominal obesity, TSFT, MUAC 
WHO cut-off points and risk of metabolic complications: (Waist circumference and waist–hip ratio, 
Report of a WHO expert consultation, Geneva, 8-11 December 2008) 
 
Indicator  Cut-off points (abdominal obesity) 
Risk of metabolic 
complications  
Waist circumference  >94 cm (M);      >80 cm (W)  Increased  
Waist circumference  >102 cm (M);    >88 cm (W)  Substantially increased  
Waist–hip ratio  ≥0.90 cm (M);   ≥0.85 cm (W)  Substantially increased  
 
 M, men; W, women   
 
 Anthropometric measurements 
Indicator Gender Normal values  Values showing malnutrition 
Triceps skinfold thickness (TSFT) 
Male  11–12.5 mm  7.5–11 mm 
Female  15–16.5 mm  10–15 mm 
Mid upper arm circumference (MUAC) Male  26–29.0 cm  20–26 cm 
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Appendix 8: Demonstration of how to measure MUAC 
www.webmd.com › Diabetes › Guide 
Appendix 9: Normal ranges of haematological and biochemical 
parameters
Parameters Normal range/ values Our reference range 
Haemoglobin (g/dL) 
13.5-17.5 (Male) 
12.0-15.5 (Female) MayoClinic.org 
White cell count (x109/L) 3.5-10.5 MayoClinic.org 
Platelet count (x109/L) 150-450 MayoClinic.org 
INR </=1.1 MayoClinic.org 
Serum creatinine (umol/L) 74.3 - 107 MayoClinic.org 
Serum albumin (g/dL) 3.5 - 5.0 
Clinical Methods: The History, Physical, 
and Laboratory Examinations. 3rd edition 
Fasting plasma glucose 
(mmol/L) 
≥ 7.0 
Definition and diagnosis of diabetes 
mellitus and intermediate hyperglycaemia. 
Report of a WHO/IDF Consultation 
HbA1c <5.7% www.webmd.com › Diabetes › Guide 
